<?xml version="1.0"?>
<Articles JournalTitle="Acta Biochimica Iranica">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Biochimica Iranica</JournalTitle>
      <Issn>0001-5261</Issn>
      <Volume>3</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2025</Year>
        <Month>06</Month>
        <Day>20</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Aqueous chicory seed extract ameliorates diabetic kidney damage via alteration of renal renin-angiotensin system (RAS) balance</title>
    <FirstPage>90</FirstPage>
    <LastPage>100</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Samin</FirstName>
        <LastName>Ardalani</LastName>
        <affiliation locale="en_US">Department of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Masoumeh</FirstName>
        <LastName>Babaei Khalili</LastName>
        <affiliation locale="en_US">Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Azin</FirstName>
        <LastName>Nowrouzi</LastName>
        <affiliation locale="en_US">Department of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>07</Month>
        <Day>02</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>07</Month>
        <Day>20</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Objectives:&#xA0; This study investigated the effects of aqueous chicory seed extract (CSE), metformin (Met), and aspirin (Asp) on the Renin-Angiotensin System (RAS) in healthy Wistar rats, as well as in early (NIA/STZ) and late-stage diabetes (STZ).
Methods:&#xA0;Rats were divided into Control, NIA/STZ, and STZ groups. NIA/STZ rats received niacinamide/streptozotocin, while STZ rats received STZ to induce early and late diabetes stages. Subgroups received CSE (125 mg/kg), metformin (100 mg/kg), or aspirin (120 mg/kg). Measurements included mRNA levels of AGT, ACE, ACE2, activities of ACE and ACE2, levels of Ang II and Ang-(1-7), protein carbonyl content (PCC), nitric oxide (NO), and kidney collagen.
Results:&#xA0;Late-stage diabetes (STZ) decreased AGT, ACE, and ACE2 mRNA, but increased ACE activity, Ang II, Ang-(1-7), the ACE/ACE2 ratio, PCC, and collagen. CSE increased AGT and ACE2 mRNA, decreased ACE activity, Ang II, the ACE/ACE2 ratio, and PCC. Metformin boosted AGT mRNA and reduced PCC and collagen. Aspirin lowered collagen. Early diabetes (NIA/STZ) decreased AGT, ACE2, and Ang-(1-7), while increasing ACE activity and Ang II levels. CSE increased AGT and Ang-(1-7), reducing Ang II and the Ang II/Ang-(1-7) ratio. Metformin reduced ACE mRNA and increased Ang-(1-7). CSE decreased reactive oxygen species (ROS) and improved Ang-(1-7) levels, especially in early stages. Both CSE and metformin helped reduce fibrosis.
Conclusion: &#xA0;&#xA0;&#xA0;&#xA0;Our findings suggest that CSE supports renal tissue repair in both early and late stages of T2D by increasing the levels of the protective peptide Ang-(1-7), respectively.</abstract>
    <web_url>https://abi.tums.ac.ir/index.php/abi/article/view/135</web_url>
    <pdf_url>https://abi.tums.ac.ir/index.php/abi/article/download/135/108</pdf_url>
    <pdf_url>https://abi.tums.ac.ir/index.php/abi/article/download/135/109</pdf_url>
  </Article>
</Articles>
